Hepatitis Clinical Trials

Showing 61-80 of 2,113 trials

To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .

NCT06168383

A double-blind placebo controlled, randomized, Phase 2b study to evaluate the efficacy and safety of once-daily, oral administration of 80 or 160 mg HSK31679 versus matching placebo in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis.

Non-Alcoholic Steatohepatitis (NASH)

Haisco Pharmaceutical Group Co., Ltd.186 participantsStarted Jan 2024

Beijing, China

RECRUITINGPhase 3

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT06318169

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis

89bio, Inc.1,350 participantsStarted Mar 2024

Birmingham, Alabama, United States • Chandler, Arizona, United States • Flagstaff, Arizona, United States +328 more locations

To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Related Searches

Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.

Stopping Antiviral Treatment in Chronic Hepatitis B

Tocotrienol Against the Progression of End Stage Liver Disease

Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings

A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection

MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo

Facilitated Telemedicine in the Catholic Health System

HepB mAb19 in Individuals With Chronic Hepatitis B Infection

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking

Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children

Statins for the Treatment of NASH

PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis